°ÄÃÅÁùºÏ²Ê¿ª½±¼Ç¼

Introduction

DNA sequencing technology has undergone a revolution to achieve over a million-fold improvement in efficiency of data generation.  There is now an opportunity for routine adoption of genome sequencing in research and healthcare. Genomes are decoded in a single rapid test that provides improved disease diagnosis to aid treatment. Early applications, include rare, undiagnosed genetic diseases and cancer, exemplified by the 100,000 Genomes project with Genomics England and the National Health Service.  The same approach will help widespread implementation of risk profiling, early detection and potentially prevention of cases of common disease in national populations, as healthcare evolves to embrace precision medicine. This technology is being used to sequence the SARS-Cov-2 (Covid19) virus and its variants
 

Deadlines

• May 03 2021
  Early bird registration deadline

  
• May 17 2021
  Standard registration deadline

  

Speakers

• Dr David Bentley Chief Scientist
  Illumina Inc. Cambridge, United Kingdom

---

Venue

Online

Online, United Kingdom

Committee

• Nick Gudde Chairman, Marketing Interest Group, °ÄÃÅÁùºÏ²Ê¿ª½±¼Ç¼, United Kingdom
• Philip Howard Committee Member, Marketing Interest Group, °ÄÃÅÁùºÏ²Ê¿ª½±¼Ç¼, United Kingdom

---

Organised by

°ÄÃÅÁùºÏ²Ê¿ª½±¼Ç¼ Marketing Interest Group
We arrange early evening talks with a general theme of "marketing chemistry", highlighting practical applications of chemicals and chemical services across the range of chemical disciplines, industry sectors and government activities. These talks are a great way of seeing what goes on in other parts of chemistry and what other chemists do for a living.  The events are a chance to share our passion for chemistry.  This is a general interest talk so the invitation has also been sent to local section members.  We also welcome 6th form and university students who want to find out more the business of chemistry.
 

Contact information

Alan Bodley
+44 (0)7704 552790
Contact us by email

---